Safety of COVID-19 vaccines: what we need to know
Data:
19/02/2021
As the world rolls out COVID-19 vaccines, many people are asking what to expect – in particular, are these vaccines safe? The answer is yes, but here’s a bit more information you may find useful.
Ver detalhes
Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Vacinas Virais/imunologia, COVID-19
WHO’s Science in 5 on COVID-19: vaccine dosage
Data:
19/02/2021
How far apart should the doses of vaccines be? What if I miss my second dose? Can I get two doses from two different manufacturers? How was safety of vaccines ensured?
Ver detalhes
Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Programas de Imunização/organização & administração, Vacinas Virais/administração & dosagem, Relação Dose-Resposta Imunológica, COVID-19
Follow the journey of a vaccine
Data:
04/02/2021
From clinic trials and emergency use listing to production, transportation, storage and final administration by local health workers – follow the journey of a vaccine.
Ver detalhes
Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Vacinas Virais/normas, COVID-19
Here is how Pfizer/BioNTech COVID-19 vaccine should be used
Data:
03/02/2021
The Pfizer/BioNTech COVID-19 vaccine is the first vaccine to receive WHO validation for emergency use. Here is how it should be used.
Ver detalhes
Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Programas de Imunização/organização & administração, Vacinas Virais/provisão & distribuição, COVID-19, Pfizer, BioNTech
The road to a COVID-19 vaccine
Data:
01/02/2021
Developing a vaccine is a long road full of checkpoints. Each phase designed to make sure it is both effective and safe. But with the whole world struggling to contain a pandemic, and unprecedented amounts of funding available, the road to finding the COVID-19 vaccine looks more like this.
Ver detalhes
Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Programas de Imunização/organização & administração, Vacinas Virais/provisão & distribuição, COVID-19
COVID-19 live Q&A about vaccines, diagnostics & therapeutics safety. Ask WHO of 20 January 2021
Data:
20/01/2021
#AskWHO series: This was the live discussion of 20 January 2021 about the COVID-19 vaccines, diagnostics and therapeutics safety assessment and approvals for use.
Ver detalhes
Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Vacinas Virais/imunologia, Terapias em Estudo, Monitoramento Epidemiológico, COVID-19
COVID-19 vaccines live Q&A with Dra Kate L. O´Brien and Dr Alejandro Cravioto. Ask WHO of 7 Jan. 2021
Data:
07/01/2021
AskWHO series: This was the live discussion about the COVID-19 pandemic of 7 January 2021 with Dr Alejandro Cravioto, Chair of the WHO Strategic Advisory Experts Group on Immunization and Dr Katherine O’Brien, Head of WHO Immunization, Vaccines and Biologicals department answer questions about COVID-19 vaccines from the general public.
Ver detalhes
Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Protocolo de Ensaio Clínico, Vacinas Virais/imunologia, Relação Dose-Resposta Imunológica, Vacinas Virais/efeitos adversos, Vacinas Virais/provisão & distribuição, Acesso a Medicamentos Essenciais e Tecnologias em Saúde, COVID-19
How COVID-19 vaccines are able to be developed so fast?
Data:
07/12/2020
WHO Chief Scientis, Dr Soumya Swaminathan, explains why COVID-19 vaccines are able to be developed so fast.
Ver detalhes
Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Vacinas Virais/imunologia, COVID-19
WHO's Science in 5 on COVID-19: evolution of the SARS-CoV-2 virus
Data:
05/03/2021
What is the latest information on the SARS-CoV-2 virus variants? How is WHO tracking these virus mutations globally and how do we know which ones are important? Answering these questions in this episode of Science in 5 is WHO's Dr. Maria Van Kerkhove.
Ver detalhes
Betacoronavirus/genética, Pandemias/prevenção & controle, Comunicação em Saúde, Infecções por Coronavirus/genética, Pneumonia Viral/genética, Monitoramento Epidemiológico, Mutação/genética, DNA Viral/genética, COVID-19
Vaccines are life-saving interventions
Data:
09/09/2020
In the context of COVID-19 vaccine research, Dr Soumya Swaminathan, WHO Chief Scientist, talks about the pivotal role that vaccines have played in saving millions of lives. She also explains the rigorous process that vaccines must go through before being certified as safe.
Ver detalhes
Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Vacinas Virais/imunologia, COVID-19